Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (ChIPseq)

Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination

Chromatin structure dynamics during human cardiomyocyte differention reveals a role of HERV-H in demarcating TAD boundaries.

Transcriptomic profiling of MDA-MB-468 cells treated with TNFɑ [40 ng/ml] ± Apigenin [40 μM].

PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer

RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS)

CircMYBL2 Regulates FLT3-ITD FLT3AML Translation in AML

SFRPs Are Biphasic Modulators of Wnt Signaling-elicited Cancer Stem Cell Properties beyond Extracellular Control

Epigenetic Silencing of TGFBI Confers Resistance to Trastuzumab in Human Breast Cancer

HEK293 TFAM Knockout Methylation Study

GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm

Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq)

Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition

Pentoxifylline-induced differentially-expressed genes in hypertrophic scar fibroblasts

BCDIN3D regulates tRNAHis 3’ fragment processing

The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures

Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models.

Novel Race-specific Genetic and Epigenetic Determinants of ADT-Resistance in African American Prostate Cancer

Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy